-
Article
Open AccessMelan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
Clear cell sarcoma (CCS), initially named malignant melanoma of soft parts, is an aggressive soft tissue sarcoma (STS) that, due to MITF activation, shares with melanoma the expression of melanocyte differenti...
-
Article
Open AccessAnthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study
Extraskeletal myxoid chondrosarcoma (EMC) is a rare subgroup within soft tissue sarcomas. Its sensitivity to chemotherapy is reported to be low.
-
Article
Open AccessStructured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
Alveolar soft part sarcoma (ASPS) is a rare soft tissue sarcoma and the clinical management of patients with unresectable, metastatic disease is still challenging. ASPS expresses an array of potentially therap...
-
Article
Open AccessExtraskeletal myxoid chondrosarcoma: tumor response to sunitinib
Extraskeletal myxoid chondrosarcoma (EMCS) is a rare soft tissue sarcoma of uncertain differentiation, characterized in most cases by a translocation that results in the fusion protein EWSR1-CHN (the latter even ...
-
Article
Targeted therapy in GIST: in silico modeling for prediction of resistance
New techniques, such as crystallography and three-dimensional modeling, can be used to assist the development of selective targeted agents for cancer treatment. In this Review, Pierotti and colleagues discuss ...
